Earlier reports suggested that SIRT6 activation can improve glucose-induced insulin secretion and thus, pharmacological activation of SIRT6 may serve as the potential therapeutic approach to attenuate DM [62,105]. This evidence concerns the gene INS and diabetes mellitus.